Max Liebregts

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry

Josef Veselka, Morten K. Jensen, Max Liebregts et al. · European Heart Journal · 2016 · 197 citations · Full text

Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Pieter A. Vriesendorp, Arend F. L. Schinkel, Max Liebregts et al. · Circulation Arrhythmia and Electrophysiology · 2015 · 138 citations

Chloroquine-induced QTc prolongation in COVID-19 patients

Marcel P. H. van den Broek, Julia E. Möhlmann, B G S Abeln et al. · Netherlands Heart Journal · 2020 · 125 citations · Full text

Long-Term Outcomes After Medical and Invasive Treatment in Patients With Hypertrophic Cardiomyopathy

Pieter A. Vriesendorp, Max Liebregts, Robbert Steggerda et al. · JACC Heart Failure · 2014 · 118 citations

Cardiomyopathy, Heart Failure, Invasive Treatment +9

Periprocedural Complications and Long-Term Outcome After Alcohol Septal Ablation Versus Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy

Robbert Steggerda, Kevin Damman, Jippe C. Balt et al. · JACC: Cardiovascular Interventions · 2014 · 71 citations · Full text

Heart Failure, Cardiothoracic Surgery, Medicine +6